EUVIMEDEUVIMED entdecken
Crossref

Malic enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells

Zhenxi Zhang, Yanting Yang, Yang Chen, Jingyu Su, Wenjing Du

Molecular Cell · 2024

DOI: 10.1016/j.molcel.2024.07.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2024. Verfasst von Zhenxi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Cell Biology, Institute of Ba…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Death-Associated Protein Kinases, Fumarates, Lymphocyte Activation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Meteorological Sciences, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The functional integrity of CD8+ T cells is closely linked to metabolic reprogramming; therefore, understanding the metabolic basis of CD8+ T cell activation and antitumor immunity could provide insights into tumor immunotherapy. Here, we report that ME2 is critical for mouse CD8+ T cell activation and immune response against malignancy. ME2 deficiency suppresses CD8+ T cell activation and anti-tumor immune response in vitro and in vivo. Mechanistically, ME2 depletion blocks the TCA cycle flux, leading to the accumulation of fumarate. Fumarate directly binds to DAPK1 and inhibits its activity by competing with ATP for binding. Notably, pharmacological inhibition of DAPK1 abolishes the anti-tumor function conferred by ME2 to CD8+ T cells. Collectively, these findings demonstrate a role for ME2 in the regulation of CD8+ T cell metabolism and effector functions as well as an unexpected function for fumarate as a metabolic signal in the inhibition of DAPK1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesDeath-Associated Protein KinasesFumaratesLymphocyte ActivationAnimalsHumansMiceAdenosine TriphosphateCell Line, TumorEnergy MetabolismMice, Inbred C57BLMice, KnockoutSignal Transduction

Stichwörter der Autor:innen

CD8(+) T cellDAPK1antitumor immunityfumaratemalic enzyme 2metabolite sensing

Substanzen

Adenosine TriphosphateDapk1 protein, mouseDeath-Associated Protein KinasesFumarates

Autor:innen und Institutionen

  • State Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Cell Biology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Ba…

Förderung

  • National Key Research and Development Program of China
  • Chinese Academy of Meteorological Sciences
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Zhang, Z., Yang, Y., Chen, Y., Su, J., & Du, W. (2024). Malic enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.07.021

Vancouver

Zhang Z, Yang Y, Chen Y, Su J, Du W. Malic enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells. Molecular Cell. 2024. doi:10.1016/j.molcel.2024.07.021

BibTeX
@article{Zhang2024,
  author = {Zhang, Zhenxi and Yang, Yanting and Chen, Yang and Su, Jingyu and Du, Wenjing},
  title = {Malic enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells},
  journal = {Molecular Cell},
  year = {2024},
  doi = {10.1016/j.molcel.2024.07.021}
}
Kostenlos starten →